Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Archangels

Investor type Angel Group

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 62
Average round size
info
The average size of a deal this fund participated in
$1M
Portfolio companies 33
Rounds per year 2.07
Lead investments 19
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.47
Exits 9
Key employees 2
Stages of investment
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Medical Device
  • Medical
Summary

Archangels appeared to be the VC, which was created in 1992. The company was established in Europe in United Kingdom. The leading representative office of defined VC is situated in the Edinburgh.

We also calculated 2 valuable employees in our database.

Among the most popular portfolio startups of the fund, we may highlight Bio-Images Drug Delivery, Adventi, Canopy Biosciences. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most successful fund investment fields, there are Health Care, Medical. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups.

This Archangels works on 14 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. Despite it in 2019 the fund had an activity. Deals in the range of 1 - 5 millions dollars are the general things for fund. The fund is constantly included in 2-6 investment rounds annually. The higher amount of exits for fund were in 2016. The real fund results show that this VC is 26 percentage points more often commits exit comparing to other companies.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Archangels, startups are often financed by Tweed Renaissance Investors Capital, Barwell Plc, Scottish Enterprise. The meaningful sponsors for the fund in investment in the same round are Tweed Renaissance Investors Capital, Par Equity, Barwell Plc. In the next rounds fund is usually obtained by Tweed Renaissance Investors Capital, Scottish Enterprise, Barwell Plc.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Archangels:
Typical Co-investors
Archangels is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Archangels:
There are no funds here. If we find new data, we will add it here.

Funds with similar focus

Funds from United Kingdom
Funds with similar focus located in United Kingdom:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Earth Blox

$2M13 Jun 2022 Edinburgh, Scotland, United Kingdom

BioCaptiva

Health Care
Medical
Medical Device
$2M01 Jun 2022 City of Edinburgh, Scotland, United Kingdom

BioCaptiva

Health Care
Medical
Medical Device
$1M06 Apr 2021 City of Edinburgh, Scotland, United Kingdom

Bio-Images Drug Delivery

Biopharma
Biotechnology
Health Care
Life Science
Pharmaceutical
$1M15 Dec 2020 United Kingdom, Glasgow

Integrated Graphene

Manufacturing
$4M09 Nov 2020 Stirling, Stirling, United Kingdom

Speech Graphics

Software
$2M13 Mar 2020 City of Edinburgh, Scotland, United Kingdom

Optoscribe

3D Technology
Manufacturing
Optical Communication
Telecommunications
$3M02 Mar 2020 United Kingdom, Scotland, United Kingdom

Calcivis

Biotechnology
Health Care
Medical
Medical Device
$6M04 Sep 2019 United Kingdom, Scotland

MGB Biopharma

Biotechnology
Health Care
Medical Device
30 Aug 2019 Tonbridge and Malling, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Archangels?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: